Bendamustine-Bortezomib-Dexamethasone (BVD) in Heavily Pretreated Multiple Myeloma: Old/New in NOVEL Agents' Era

被引:2
|
作者
Cerchione, Claudio
Catalano, Lucio
Nappi, Davide
Rocco, Stefano
Palmieri, Salvatore
Pareto, Anna Emanuele
Musuraca, Gerardo
Lucchesi, Alessandro
Pane, Fabrizio
Ferrara, Felicetto
Martinelli, Giovanni
机构
关键词
D O I
10.1182/blood-2020-143207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Selinexor in combination with dexamethasone with or without bortezomib in heavily pretreated multiple myeloma: A case series
    Aung, Nini
    Bowers, Margaret
    Brearton, Gillian
    Charlton, Andrew
    Craig, Joanne
    Cullis, Jonathan
    Dang, Ray
    Donaldson, David
    Drake, Mary
    Hall, Rachel
    Parkins, Elizabeth
    Tighe, Jane
    Bygrave, Ceri
    Sheehy, Oonagh
    EJHAEM, 2024, 5 (05): : 987 - 991
  • [32] A single-center retrospective analysis of first-line therapy of multiple myeloma with bendamustine-bortezomib-dexamethasone
    Zwickl, Hannes
    Zwickl-Traxler, Elisabeth
    Pecherstorfer, Martin
    LEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2065 - 2070
  • [33] Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated
    Ludwig, Heinz
    Kasparu, Hedwig
    Greil, Richard
    Leitgeb, Clemens
    Muelduer, Ercan
    Rauch, Elisabeth
    Zojer, Niklas
    Autzinger, Eva Maria
    Linkesch, Werner
    Kuhr, Thomas
    Pour, Ludek
    Adam, Zdenek
    BLOOD, 2012, 120 (21)
  • [34] Lenalidomide (Revlimid), Bortezomib (Velcade) and Dexamethasone (RVD) for Heavily Pretreated Relapsed or Refractory Multiple Myeloma
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Chen, Christine
    Kukreti, Vishal
    BLOOD, 2011, 118 (21) : 1266 - 1267
  • [35] BENDAMUSTINE, BORTEZOMIB AND DEXAMETHASONE (BVD) COMBINATION FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: AN INTERIM ANALYSIS OF A PHASE II STUDY
    Offidani, M.
    Corvatta, L.
    Caraffa, P.
    Liberati, A. M.
    Alesiani, F.
    Brunori, M.
    di Toritto, T. Caravita
    Gentili, S.
    Attolico, I.
    Mele, A.
    Pulini, S.
    Ballanti, S.
    Galimberti, S.
    Gozzetti, A.
    Coppetelli, U.
    Ledda, A.
    Leoni, P.
    HAEMATOLOGICA, 2012, 97 : 353 - 353
  • [36] Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients
    Delforge, Michel
    Raddoux, Jolien
    Antonis, Corine
    Clement, Celine
    Kint, Nicolas
    Vanhellemont, Anneleen
    Bravetti, Julie
    Vandenberghe, Peter
    ONCOTARGETS AND THERAPY, 2022, 15 : 243 - 250
  • [37] Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM)
    Offidani, Massimo
    Corvatta, Laura
    Maracci, Laura
    Liberati, Anna Marina
    Ballanti, Stelvio
    Attolico, Immacolata
    Caraffa, Patrizia
    Alesiani, Francesco
    di Toritto, Tommaso Caravita
    Gentili, Silvia
    Tosi, Patrizia
    Brunori, Marino
    Derudas, Daniele
    Ledda, Antonio
    Gozzetti, Alessandro
    Cellini, Claudia
    Malerba, Lara
    Mele, Anna
    Andriani, Alessandro
    Galimberti, Sara
    Mondello, Patrizia
    Pulini, Stefano
    Coppetelli, Ugo
    Fraticelli, Paolo
    Olivieri, Attilio
    Leoni, Pietro
    BLOOD, 2013, 122 (21)
  • [38] Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
    Cerchione, Claudio
    Martinelli, Giovanni
    Catalano, Lucio
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S5 - S5
  • [39] Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Pareto, Anna Emanuele
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Ronconi, Sonia
    Ceccolini, Michela
    Cangini, Delia
    Giannini, Maria Benedetta
    Di Battista, Valeria
    Simonetti, Giorgia
    Di Rora, Andrea Ghelli Luserna
    Pane, Fabrizio
    Martinelli, Giovanni
    BLOOD, 2020, 136
  • [40] POMALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF HEAVILY PRETREATED MULTIPLE MYELOMA
    Cerchione, C.
    Martinelli, G.
    Nappi, D.
    Pareto, A. E.
    Di Perna, M.
    Ferrara, K.
    Ronconi, S.
    Cangini, D.
    Di Battista, V.
    Ceccolini, M.
    Altini, M.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2019, 104 : 116 - 116